Should DEI DIE? [0.03%]
多样性和包容性部门应该被取消吗？
Stephen A Brunton
Stephen A Brunton
Profiling of Macrovascular and Microvascular Complications in Young-Onset Type 2 Diabetes: A Scoping Review [0.03%]
青年发病2型糖尿病大血管和微血管并发症特征分析的述评研究
Anupama Harihar,G Arun Maiya,Sahana Shetty et al.
Anupama Harihar et al.
Young-onset type 2 diabetes is defined as type 2 diabetes diagnosed before the age of 40 years. It is characterized by more aggressive pathology compared with type 2 diabetes diagnosed later in life, leading to earlier susceptibility to mac...
Person-Centered Care and Telehealth Reduce Distress and A1C for Marginalized Adolescents and Young Adults With Type 1 Diabetes [0.03%]
以患者为中心的关怀和远程医疗可降低边缘化青少年和年轻成人1型糖尿病患者的焦虑感和糖化血红蛋白水平
Jaquelin Flores Garcia,Mark W Reid,Elizabeth A Pyatak et al.
Jaquelin Flores Garcia et al.
Compared with their peers, historically excluded and marginalized adolescents and young adults (AYAs) with type 1 diabetes experience more adverse diabetes outcomes. The Colorado Youth With Type 1 Diabetes (CoYoT1) Care program (offering pe...
Nutrition Interventions for Remission of Type 2 Diabetes: Potential Role for Diabetes-Specific Nutrition Formulas [0.03%]
糖尿病缓解的营养干预：糖尿病专用营养配方的潜在作用
Michael Trenell,Harpreet Bajaj,Jeffrey I Mechanick et al.
Michael Trenell et al.
Designing a Structured Insulin Pump Program Pathway and Reducing Wait Times in the Diabetes Clinic at BC Children's Hospital [0.03%]
设计BC儿童医院结构化的胰岛素泵项目路径并减少糖尿病诊所的等待时间
Fatema S Abdulhussein,Sanjukta Basak,Deep McGregor et al.
Fatema S Abdulhussein et al.
Quality Improvement Success Stories are published by the American Diabetes Association in collaboration with the American College of Physicians and the National Diabetes Education Program. This series is intended to highlight best practices...
Development of a Diabetes Navigator Toolkit to Support Diabetes Technology Uptake: The IMPACT Toolkit [0.03%]
糖尿病技术采纳支持工具包的研发——IMPECT工具包
Risa M Wolf,Neha Parimi,Defne Alver et al.
Risa M Wolf et al.
Advanced diabetes technologies (ADTs), including continuous glucose monitoring devices, insulin pumps, and automated insulin delivery systems, improve glycemic control in type 1 diabetes but are underutilized, particularly in minority and u...